Brain Hemorrhage Treatment Market Overview on Future Threats by 2027 – Commerce Gazette

Posted: Published on September 22nd, 2019

This post was added by Alex Diaz-Granados

Brain hemorrhage, also called brain bleed, is a type of stroke, wherein bleeding happens in the brain. The causes of brain hemorrhage include high blood pressure, trauma, injuries, brain tumor, aneurysm, certain blood disorders, blood vessel abnormalities, and liver disease.The artery in the brain bursts leading to hemorrhage. Depending on the location of bleeding, there are various types of brain hemorrhage. These are subdural hemorrhage, extradural hemorrhage, subarachnoid hemorrhage, and intracerebral hemorrhage. Subdural hemorrhage occurs at the outer side of the brain and it can lead to medical emergency. Extradural hemorrhage is collection of blood between inner surface of skull and endosteal layer. Subarachnoid hemorrhage takes place in subarachnoid space in the brain and is usually caused by a rupture of brain aneurysm, an abnormal bulge in the blood vessel of brain. Intracerebral hemorrhage is bleeding in the brain tissue itself due to deprivation of blood supply and oxygen in the brain. Symptoms of brain hemorrhage include nausea, vomiting, loss of coordination, changes in vision, severe headache, difficulty in speaking, and loss of consciousness. The commonly used diagnostic tests for brain hemorrhage are computed tomography angiography (CTA), cerebrospinal fluid exam, lumbar puncture, angiogram, MRI,and X-rays. Increase in incidence of traumatic brain injuries, surge in awareness about brain hemorrhage in developing countries, technological advancements, rise in prevalence of stroke, rich product pipeline, and increase in R&D spending are the major factors expected to drive the global brain hemorrhage treatment market. However, complications associated with the treatment are likely to restrain the brain hemorrhage treatment market.

The global brain hemorrhage treatment market can be segmented based on treatment type and end-user. In terms of treatment type, the brain hemorrhage treatment market can be classified into surgery and medications. The medications segment held the larger share of the market in 2017 due to high preference to medications for the treatment of brain hemorrhage. The medications segment can be categorized into anti-hypertensive drugs, anti-anxiety drugs, hyperosmotic drugs, and anti-seizure drugs. The anti-hypertensive drugs segment dominated the market in 2017 and is projected to sustain its leadership position during the forecast period. This is because anti-hypertensive drugs are first line of treatment for brain hemorrhage. Based on end-user, the global brain hemorrhage treatment market can be divided into hospitals, ambulatory surgery centers, and others. The hospitals segment dominated the market in 2017 and the trend is anticipated to continue from 2018 to 2026.

Browse more detail information about this report visit at at https://www.transparencymarketresearch.com/brain-hemorrhage-treatment-market.html

In terms of region, the global brain hemorrhage treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market in 2017 due to high prevalence of traumatic brain injuries in the U.S. An article published by the Centers for Disease Control and Prevention (CDC) in 2017 stated that approximately 2.8 million people in the U.S. suffer from traumatic brain injury. Traumatic brain injuries is a leading cause of all injury-related deaths in the U.S. and account for nearly 30% of injury-related deaths in the country. The brain hemorrhage treatment market in Asia Pacific is anticipated to expand at the highest CAGR owing to increase in incidence of brain hemorrhage, surge in awareness, and improvement in health care infrastructure.

Major players operating in the global brain hemorrhage treatment market include Baxter, Pfizer, Inc., F. Hoffmann-La Roche Ltd., Novartis AG, Abbott, Bristol-Myers Squibb, Siemens Healthcare GmbH, and Novo Nordisk A/S.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Request For Custom Research At https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=61284&source=atm

The study is a source of reliable data on: Market segments and sub-segments Market trends and dynamics Supply and demand Market size Current trends/opportunities/challenges Competitive landscape Technological breakthroughs Value chain and stakeholder analysis

The regional analysis covers: North America (U.S. and Canada) Latin America (Mexico, Brazil, Peru, Chile, and others) Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg) Eastern Europe (Poland and Russia) Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand) Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industrys value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report: A complete backdrop analysis, which includes an assessment of the parent market Important changes in market dynamics Market segmentation up to the second or third level Historical, current, and projected size of the market from the standpoint of both value and volume Reporting and evaluation of recent industry developments Market shares and strategies of key players Emerging niche segments and regional markets An objective assessment of the trajectory of the market Recommendations to companies for strengthening their foothold in the market

Note: Although care has been taken to maintain the highest levels of accuracy in TMRs reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Request for TOC of This Report visit at https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=61284&source=atm

Read more here:
Brain Hemorrhage Treatment Market Overview on Future Threats by 2027 - Commerce Gazette

Related Posts
This entry was posted in Brain Injury Treatment. Bookmark the permalink.

Comments are closed.